The Science of Early Cancer Detection

OncoSure uses rapid in situ hybridization and DNA fluorescent probes to detect chromosomal changes linked to cancer — even at the earliest stages — enabling fast, affordable, and comprehensive screening without invasive procedures.

All Human Cancers

Comprehensive testing for every type of cancer with advanced genomic analysis

Results in 24 Hours

Get your results the next day, no weeks of waiting, no anxiety limbo

97.7% Accuracy

Industry-leading precision with validated clinical-grade testing protocols

For Providers

OncoSure’s
 Advanced Cancer Screening
 Technology.

Detecting cancer can be challenging due to limited existing screening tests, long turnaround times, high costs, and invasive procedures. OncoSure’s innovative technology allows for early detection, even at stage -1, and provides crucial information for guiding further imaging tests with our detailed Oncosome count.

OncoSure’s advanced cancer screening technology utilizes rapid in situ hybridization and DNA fluorescent probes, offering comprehensive cancer screening with high accuracy. Our approach includes a rapid SITU Hybridization Platform, DNA Fluorescent Probes for ploidy detection, and inexpensive density gradient and low sequential centrifugation, which enable comprehensive screening for aneuploidy of all chromosomes.

The Science Behind OncoSure

OncoSure leverages cutting-edge technology to redefine cancer diagnostics.

Oncosomes: Cancer Specific Markers
Oncosomes are microscopic vesicles unique to cancer cells. By isolating and analyzing these, OncoSure achieves high specificity and sensitivity in early cancer detection.

Advanced Hybridization Technology
Utilizing rapid in situ hybridization and DNA fluorescent probes, OncoSure offers comprehensive screening for aneuploidy across all chromosomes, ensuring thorough and accurate results.

Expert Leadership: Dr. Ramesh Babu
Developed under the guidance of Dr. Ramesh Babu, a pioneer in cancer research with extensive experience in oncology and molecular diagnostics, OncoSure reflects a commitment to advancing early detection methods for improved patient outcomes.

CLINICAL STUDY

Download OncoSure's Cancer Clinical Study Report

Download our comprehensive whitepaper to learn more about the latest advancements in cancer testing technology and how OncoSure is paving the way for faster, more accurate cancer detection.

Our Expert Team

World-Class Scientists & Laboratory Professionals
Our team of board-certified physicians, molecular scientists, and laboratory professionals brings decades of experience in molecular diagnostics, pathology, and precision medicine to deliver the highest quality testing services.

Double Board-Certified

Dr. Phoutthasone Thirakul, MD
Laboratory Director

Pathology & Forensic Medicine

 
Education:
University of California, San Diego (MD)
University of South Florida (Fellowship)
 
Areas of Expertise:

Anatomic & Clinical Pathology

Forensic Pathology

Laboratory Operations

Oversees all clinical and operational aspects of the laboratory, ensuring compliance with regulatory standards and maintaining the highest levels of diagnostic accuracy.

Advanced Certifications

Jahmar Hudson
Chief Scientific Officer & Technical Supervisor
Molecular Diagnostics & Pharmacogenomics
 
Education:
University of Cincinnati (MS Pharmacogenomics)
Nova Southeastern University (PhD in progress)
 
Areas of Expertise:

Molecular Diagnostics

Pharmacogenomics

Quality Assurance

Provides scientific leadership and technical oversight of molecular diagnostics, focusing on assay development, validation, and regulatory compliance.

CLIA Supervisor

Stephanie Altidort
General Supervisor, Molecular Pathology
Molecular Diagnostics & Genomics
 
Education:
Florida Atlantic University (BS Neuroscience)

Areas of Expertise:

High-Complexity Testing

Quality Control

Staff Management

Supervises high-complexity molecular testing procedures and ensures compliance with CLIA regulatory standards and laboratory accreditation requirements.

Clinical Specialist

Stephanie Lucce
Molecular Technologist
Biotechnology & Molecular Pathology
 
Education:

Miami Dade College (BS Biotechnology)

Areas of Expertise:

PCR Techniques

Nucleic Acid Analysis

Genetic Testing

Executes high-complexity molecular assays including nucleic acid extraction, PCR amplification, and genetic analysis for infectious diseases and genetic conditions.

20+ Years Experience

William Wysock
Molecular Scientist
Validation & Process Development
 
Education:
Catholic University of America (MS Biology)
Loyola University (BA Writing)
 
Areas of Expertise:

Method Validation

NGS Technologies

Six Sigma Quality

Oversees validation processes and complex technical inquiries, with extensive experience in molecular methodologies and regulatory compliance.